SCHEMBL4331228

SCHEMBL4331228

COc1c(C(=O)O)ccc2c1c(-c1cc3ccccc3o1)nn2C(C(N)=O)c1nccs1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.36
MEN1 O00255 7/20 0.36
KMT2A Q03164 7/20 0.36
MAPT P10636 5/20 0.36
NPSR1 Q6W5P4 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
ALDH1A1 P00352 6/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
JAK2 O60674 2/20 0.34
JAK3 P52333 2/20 0.34
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
SYK P43405 1/20 0.33
F2RL3 Q96RI0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4341551 0.88 ALDH1A1 (0.37) KDM4EMEN1KMT2AMAPTNPSR1
SCHEMBL4334500 0.85 SRC (0.35) KDM4EMEN1KMT2AMAPTNPSR1
SCHEMBL4335815 0.84 PIK3CD (0.35) MEN1KMT2AJAK2JAK3KDM4C
SCHEMBL4334570 0.81 KDM4E (0.39) KDM4EMEN1KMT2AMAPTNPSR1
SCHEMBL4341027 0.75 KDM4E (0.40) KDM4EMEN1KMT2AMAPTNPSR1
SCHEMBL4348191 0.73 KDM4E (0.35) KDM4EMEN1KMT2AMAPTNPSR1
SCHEMBL4335938 0.72 ECE1 (0.36) KDM4EMEN1KMT2AMAPTNPSR1
SCHEMBL4339893 0.71 ACLY (0.35) JAK2JAK3KDM4C
SCHEMBL4331950 0.69 CTSA (0.37) GAACTSA
SCHEMBL4331301 0.68 KDM4E (0.41) KDM4EMEN1KMT2AMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDM4E 2531/4885MEN1 3782/4885KMT2A 2212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.